The role of SEMG1 overexpression in OSCC tumorigenesis and its relation with metabolic molecules
Oral Diseases · 2025
DOI: 10.1111/odi.15110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Jing Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Lab…. Hauptthemen laut MEDLINE: Mouth Neoplasms, Carcinoma, Squamous Cell, Carcinogenesis. Die Arbeit nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities (Wuhan University, Clinical Medicine + X), Postdoctoral Science Foundation of China.
Abstract (Originalsprache)
Objectives
This study aimed to investigate the expression and biological significance of Semenogelin 1 (SEMG1), a member of the cancer‐testis antigen family, in oral squamous cell carcinoma (OSCC). Further, we explored its potential association with metabolism‐related molecules.
Methods
SEMG1 expression levels in OSCC were determined through immunohistochemistry, flow cytometry, and Western blot analyses. To decipher the biological implications of SEMG1 in OSCC, the CAL27 OSCC cell line was either stably overexpressed with SEMG1 or subjected to SEMG1‐shRNA knockdown. The relationship between clinicopathological parameters and SEMG1 expression in OSCC patients was also assessed.
Results
SEMG1 was found to be overexpressed in OSCC, though its expression was not influenced by the pathological grade. The fluorescent dihydroethidium assay indicated that SEMG1 augmented reactive oxygen species production. The mitochondrial membrane potential assay suggested a significant upregulation of mitochondrial membrane potential by SEMG1. Cell cycle assessments highlighted that SEMG1 overexpression led to a notable rise in cells entering the S‐phase. Additionally, a strong correlation between SEMG1 expression and both ENO1 and PKM2 expression in OSCC was observed.
Conclusions
The findings underscore the elevated expression of SEMG1 in OSCC and its contributory role in the tumorigenesis of OSCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan Univer…
- Central Laboratory, Peking University School and Hospital of Stomatology, Beijing, China.
- National Clinical Research Center for Oral Diseases, Beijing, China.
- National Engineering Laboratory for Digital and Material Technology of Stomatology, Beijing, China.
- Beijing Key Laboratory of Digital Stomatology, Beijing, China.
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China.
ORCID-Profile: Bing Liu, Qi-Wen Man, Lin-Lin Bu
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities (Wuhan University, Clinical Medicine + X)
- Postdoctoral Science Foundation of China
- Hubei Province Chinese Medicine Research Project
- Natural Science Foundation of Hubei Province
- Medical Young Talents Program of Hubei Province
- Wuhan Young Medical Talents Training Project
Zitieren
APA
Wang, J., Zhong, N. N., Yi, J. R., Liu, X. H., Wang, H. Q., Liu, B., Man, Q. W., & Bu, L. L. (2025). The role of SEMG1 overexpression in OSCC tumorigenesis and its relation with metabolic molecules. Oral Diseases. https://doi.org/10.1111/odi.15110
Vancouver
Wang J, Zhong NN, Yi JR, Liu XH, Wang HQ, Liu B, et al. The role of SEMG1 overexpression in OSCC tumorigenesis and its relation with metabolic molecules. Oral Diseases. 2025. doi:10.1111/odi.15110
BibTeX
@article{Wang2025,
author = {Wang, Jing and Zhong, Nian-Nian and Yi, Jing-Rui and Liu, Xuan-Hao and Wang, Han-Qi and Liu, Bing and Man, Qi-Wen and Bu, Lin-Lin},
title = {The role of SEMG1 overexpression in OSCC tumorigenesis and its relation with metabolic molecules},
journal = {Oral Diseases},
year = {2025},
doi = {10.1111/odi.15110}
}
EUVIMED